All posts tagged
French Biotech Plans a $100M Nasdaq IPO to Support its Cancer-Fighting Red Blood Cells
French Biotech Sees Positive Phase IIb Results Against One of the Most Deadly Cancers
French Biotech and Canadian University to treat Rare Disease with Red Blood Cells
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Red Blood Cell-based Therapy Suceeds in Phase II for Pancreatic Cancer
What are the Best Countries to Recruit Biotech Talents in 2017?
These are 10 of the Hottest Biotech Hubs in Europe
Forget Paris, here are 13 Biotechs in Lyon deserving Lionization
Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed
Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease
Infographic: The Anatomy of European Biotech
This €200M French Biotech uses Red blood Cells to Fight Leukemia & Pancreatic Cancer
Labiotech UG, All Rights Reserved -
Send this to a friend